Aura Biosciences IPO

Aura Biosciences is a biotechnology company developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed.

Register for Details

For more details on financing and valuation for Aura Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Aura Biosciences's ticker symbol?


What is Aura Biosciences's stock price?

12.1 as of 6/2/23

Aura Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/22/2021 Series E $80.48MM raised $XXX.XX $XXX.XX
7/9/2020 Series D-2 $17MM raised $XXX.XX $XXX.XX
4/2/2019 Series D-1 $40MM raised $XXX.XX $XXX.XX
12/21/2017 Series C-1 and C-2 $42.41MM raised $XXX.XX $XXX.XX
3/5/2015 Series B $28.21MM raised $XXX.XX $XXX.XX
8/17/2014 Series A-2 $5.37MM raised $XXX.XX $XXX.XX
7/4/2013 Series A-1 $8.2MM raised $XXX.XX $XXX.XX
8/26/2011 Series A $3.4MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Aura Biosciences

Forge green plus iconForge green minus icon

What is Aura Biosciences funding to date?

Aura Biosciences has raised $225.08MM with the following series:
$3.4MM raised for Series A,$8.2MM raised for Series A-1,$5.37MM raised for Series A-2,$28.21MM raised for Series B,$42.41MM raised for Series C-1 and C-2,$40MM raised for Series D-1,$17MM raised for Series D-2,$80.48MM raised for Series E.
Forge green plus iconForge green minus icon

When was Aura Biosciences founded?

Aura Biosciences was founded in 2009.
Updated on: Jun 12, 2022